These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 10872614)

  • 41. Preservation of the endogenous antioxidants in low density lipoprotein by ascorbate but not probucol during oxidative modification.
    Jialal I; Grundy SM
    J Clin Invest; 1991 Feb; 87(2):597-601. PubMed ID: 1991843
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit.
    Carew TE; Schwenke DC; Steinberg D
    Proc Natl Acad Sci U S A; 1987 Nov; 84(21):7725-9. PubMed ID: 3478721
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Anti-oxidant effect of flavonoids on the susceptibility of LDL oxidation.
    Naderi GA; Asgary S; Sarraf-Zadegan N; Shirvany H
    Mol Cell Biochem; 2003 Apr; 246(1-2):193-6. PubMed ID: 12841362
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effect of xueguantong on inhibiting experimental atherosclerosis in rabbits].
    Li J; Chen KJ; Li L
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 May; 15(5):287-90. PubMed ID: 7640503
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A comparison of the antiatherogenic effects of probucol and of a structural analogue of probucol in low density lipoprotein receptor-deficient rabbits.
    Fruebis J; Steinberg D; Dresel HA; Carew TE
    J Clin Invest; 1994 Jul; 94(1):392-8. PubMed ID: 8040279
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of antioxidants against atherosclerosis.
    Niki E; Noguchi N
    Mol Cell Biochem; 2002; 234-235(1-2):19-25. PubMed ID: 12162433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Inhibitory effect of Isorhamnetin and Hesperidin on LDL oxidation induced by Cu2+].
    Liu R; Meng F; Liu Y; Bai H; Liu BW
    Zhong Yao Cai; 2007 Jun; 30(6):677-81. PubMed ID: 17918439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
    Rosenfeld ME; Khoo JC; Miller E; Parthasarathy S; Palinski W; Witztum JL
    J Clin Invest; 1991 Jan; 87(1):90-9. PubMed ID: 1985115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The protective effects of tetrahydrocurcumin on oxidative stress in cholesterol-fed rabbits.
    Naito M; Wu X; Nomura H; Kodama M; Kato Y; Kato Y; Osawa T
    J Atheroscler Thromb; 2002; 9(5):243-50. PubMed ID: 12409634
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Inhibition of human low-density lipoprotein oxidation by salvianolic acid-A].
    Liu YL; Liu GT
    Yao Xue Xue Bao; 2002 Feb; 37(2):81-5. PubMed ID: 12579947
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibitory effect of flavonoids on low-density lipoprotein peroxidation catalyzed by mammalian 15-lipoxygenase.
    da Silva EL; Abdalla DS; Terao J
    IUBMB Life; 2000 Apr; 49(4):289-95. PubMed ID: 10995031
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Restorative effect of shosaikoto (kampo medicine) on diminution of nitric oxide synthesis in murine peritoneal macrophages induced by hypercholesterolemia.
    Inoue M; Shen YR; Ogihara Y
    Biol Pharm Bull; 1996 Nov; 19(11):1468-73. PubMed ID: 8951166
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?
    Steinberg D; Witztum JL
    Circulation; 2002 Apr; 105(17):2107-11. PubMed ID: 11980692
    [No Abstract]   [Full Text] [Related]  

  • 54. Comprehensive evaluation of antioxidant effects of Japanese Kampo medicines led to identification of Tsudosan formulation as a potent antioxidant agent.
    Sato N; Li W; Takemoto H; Takeuchi M; Nakamura A; Tokura E; Akahane C; Ueno K; Komatsu K; Kuriyama N; Onoda T; Higai K; Koike K
    J Nat Med; 2019 Jan; 73(1):163-172. PubMed ID: 30374696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical trials of antioxidants in atherosclerosis: are we doing the right thing?
    Steinberg D
    Lancet; 1995 Jul; 346(8966):36-8. PubMed ID: 7603147
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antioxidants in peripheral arterial disease.
    Violi F; Loffredo L; Marcoccia A
    Curr Drug Targets Cardiovasc Haematol Disord; 2004 Sep; 4(3):289-94. PubMed ID: 15379622
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapy and clinical trials.
    Dutta-Roy AK
    Curr Opin Lipidol; 1996 Feb; 7(1):U34-7. PubMed ID: 8925178
    [No Abstract]   [Full Text] [Related]  

  • 58. [Gastrointestinal perception and Kampo].
    Oshima T; Miwa H
    Nihon Shokakibyo Gakkai Zasshi; 2010 Oct; 107(10):1604-10. PubMed ID: 20938110
    [No Abstract]   [Full Text] [Related]  

  • 59. Taking tamoxifen to heart.
    Wiseman H
    Nat Med; 1995 Dec; 1(12):1226. PubMed ID: 7489391
    [No Abstract]   [Full Text] [Related]  

  • 60. Animal studies on antioxidants.
    Afridi N; Keaney JF
    J Cardiovasc Risk; 1996 Aug; 3(4):358-62. PubMed ID: 8946265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.